메뉴 건너뛰기




Volumn 5, Issue 10, 2010, Pages 1887-1892

Fibroblast growth factor-23 and parathyroid hormone are associated with post-transplant bone mineral density loss

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; FIBROBLAST GROWTH FACTOR 23; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARATHYROID HORMONE; PHOSPHORUS; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

EID: 77958533251     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.00950110     Document Type: Article
Times cited : (35)

References (33)
  • 6
    • 34247382124 scopus 로고    scopus 로고
    • Tertiary 'hyperphosphatonism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients
    • Evenepoel P, Naesens M, Claes K, Kuypers D, Vanrenterghem Y: Tertiary 'hyperphosphatonism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am J Transplant 7: 1193-1200, 2007
    • (2007) Am J Transplant , vol.7 , pp. 1193-1200
    • Evenepoel, P.1    Naesens, M.2    Claes, K.3    Kuypers, D.4    Vanrenterghem, Y.5
  • 9
    • 3242661165 scopus 로고    scopus 로고
    • Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency
    • Shigematsu T, Kazama JJ, Yamashita T, Fukumoto S, Hosoya T, Gejyo T, Fukagawa M: Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency. Am J Kidney Dis 44: 250-256, 2004
    • (2004) Am J Kidney Dis , vol.44 , pp. 250-256
    • Shigematsu, T.1    Kazama, J.J.2    Yamashita, T.3    Fukumoto, S.4    Hosoya, T.5    Gejyo, T.6    Fukagawa, M.7
  • 12
    • 0025177134 scopus 로고
    • Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies
    • Bouillon R, Coopmans W, Deqroote DE, Radoux D, Eliard PH: Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies. Clin Chem 36: 271-276, 1990
    • (1990) Clin Chem , vol.36 , pp. 271-276
    • Bouillon, R.1    Coopmans, W.2    Deqroote, D.E.3    Radoux, D.4    Eliard, P.H.5
  • 13
    • 0003381251 scopus 로고
    • Reproducibility of bone mass measurements in human volunteers using three DPA and one dual-energy X-ray bone densitometers: Correlation between instruments
    • edited by Ring EFJ, London, British Institute of Radiology
    • Devogelaer JP, Le Thi C, Depresseux G, Nagant de Deuxchaines C: Reproducibility of bone mass measurements in human volunteers using three DPA and one dual-energy X-ray bone densitometers: correlation between instruments. In: Current Research in Osteoporosis and Bone Mineral Measurements, edited by Ring EFJ, London, British Institute of Radiology, 1990, p 36
    • (1990) Current Research in Osteoporosis and Bone Mineral Measurements , pp. 36
    • Devogelaer, J.P.1    Le Thi, C.2    Depresseux, G.3    Nagant De Deuxchaines, C.4
  • 15
    • 0036020931 scopus 로고    scopus 로고
    • Changes in bone mineral density over 18 months following kidney transplantation: The respective roles of prednisone and parathyroid hormone
    • Casez JP, Lippuner K, Horber FF, Montandon A, Jaeger P: Changes in bone mineral density over 18 months following kidney transplantation: the respective roles of prednisone and parathyroid hormone. Nephrol Dial Transplant 17: 1318-1326, 2002
    • (2002) Nephrol Dial Transplant , vol.17 , pp. 1318-1326
    • Casez, J.P.1    Lippuner, K.2    Horber, F.F.3    Montandon, A.4    Jaeger, P.5
  • 17
    • 0037442071 scopus 로고    scopus 로고
    • Bone disease after renal transplantation
    • Heaf JG. Bone disease after renal transplantation: Transplantation 75: 315-325, 2003
    • (2003) Transplantation , vol.75 , pp. 315-325
    • Heaf, J.G.1
  • 18
    • 17844410337 scopus 로고    scopus 로고
    • Osteoporosis after solid organ transplantation
    • Maalouf NM, Shane E. Osteoporosis after solid organ transplantation: J Clin Endocrinol Metab 90: 2456-2465, 2005
    • (2005) J Clin Endocrinol Metab , vol.90 , pp. 2456-2465
    • Maalouf, N.M.1    Shane, E.2
  • 19
    • 0034085591 scopus 로고    scopus 로고
    • High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation
    • Monier-Faugere MC, Mawad H, Qi Q, Friedler RM, Malluche HH: High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 11: 1093-1099, 2000
    • (2000) J Am Soc Nephrol , vol.11 , pp. 1093-1099
    • Monier-Faugere, M.C.1    Mawad, H.2    Qi, Q.3    Friedler, R.M.4    Malluche, H.H.5
  • 22
    • 0027368006 scopus 로고
    • Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis
    • Laan R, van Riel P, van de Putte L, van Erning L, van't Hof M, Lemmens A: Low-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. Ann Intern Med 119: 963-968, 1993
    • (1993) Ann Intern Med , vol.119 , pp. 963-968
    • Laan, R.1    Van Riel, P.2    Van De Putte, L.3    Van Erning, L.4    Van't Hof, M.5    Lemmens, A.6
  • 25
    • 44449118964 scopus 로고    scopus 로고
    • Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro
    • Wang H, YoshikoY, Yamamoto R, Minamizaki T, Tanne K, Aubin JE, Maeda N: Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res 23: 939-948, 2008
    • (2008) J Bone Miner Res , vol.23 , pp. 939-948
    • Wang, H.1    Yoshiko, Y.2    Yamamoto, R.3    Minamizaki, T.4    Tanne, K.5    Aubin, J.E.6    Maeda, N.7
  • 26
    • 59749105862 scopus 로고    scopus 로고
    • Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis
    • Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, Jüppner H, Salusky IB: Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab 94: 511-517, 2009
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 511-517
    • Wesseling-Perry, K.1    Pereira, R.C.2    Wang, H.3    Elashoff, R.M.4    Sahney, S.5    Gales, B.6    Jüppner, H.7    Salusky, I.B.8
  • 27
    • 0028366428 scopus 로고
    • Loss of regional bone mineral density in the first 12 months following renal transplantation
    • Almond MK, Kwan JTC, Evans K, Cunnigham J: Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 66: 52-57, 1994
    • (1994) Nephron , vol.66 , pp. 52-57
    • Almond, M.K.1    Kwan, J.T.C.2    Evans, K.3    Cunnigham, J.4
  • 29
    • 46249115645 scopus 로고    scopus 로고
    • Early bone mineral density loss after renal transplantation and pre-transplant PTH: A prospective study
    • Bubenicek P, Sotornik I, Vitko S, Teplan V: Early bone mineral density loss after renal transplantation and pre-transplant PTH: a prospective study. Kidney Blood Press Res 31: 196-202, 2008
    • (2008) Kidney Blood Press Res , vol.31 , pp. 196-202
    • Bubenicek, P.1    Sotornik, I.2    Vitko, S.3    Teplan, V.4
  • 32
  • 33
    • 23944486382 scopus 로고    scopus 로고
    • Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secobdary hyperparathyroidism
    • Nishi H, Nii-Kono T, Nakanishi S, Yamazaki Y, Yamashita T, Fukumoto S, Ikeda K, Fujimori A, Fukagawa M: Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secobdary hyperparathyroidism. Nephron Clin Pract 101: 94-99, 2005
    • (2005) Nephron Clin Pract , vol.101 , pp. 94-99
    • Nishi, H.1    Nii-Kono, T.2    Nakanishi, S.3    Yamazaki, Y.4    Yamashita, T.5    Fukumoto, S.6    Ikeda, K.7    Fujimori, A.8    Fukagawa, M.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.